These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 16489062)

  • 1. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
    Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
    Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
    Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
    Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
    Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
    Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
    Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
    Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
    Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head juxtaposition of Fas-associated phosphatase-1 (FAP-1) and c-Jun NH2-terminal kinase 3 (JNK3) genes: genomic structure and seven polymorphisms of the FAP-1 gene.
    Yoshida S; Harada H; Nagai H; Fukino K; Teramoto A; Emi M
    J Hum Genet; 2002; 47(11):614-9. PubMed ID: 12436199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
    Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
    Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
    Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
    Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
    Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
    Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
    Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
    Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of MTUS1 in human colon tumors.
    Zuern C; Heimrich J; Kaufmann R; Richter KK; Settmacher U; Wanner C; Galle J; Seibold S
    Oncol Rep; 2010 Jan; 23(1):183-9. PubMed ID: 19956880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.